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ABSTRACT 
     Esophagus cancer is the eighth most common cancer worldwide and particularly high in an area 
extending from the southern border of the Caspian Sea in Iran across central Asia to China. Since 
information about this mysterious disease is poor, proteomics may be solving this enigma. Altering 
gene expression in cancer cell is a remarkable indicator can be detected by proteomics techniques and 
bioinformatic analysis. In this study, normal and cancerous cells were obtain from patients, total 
proteins were purified by standard methods, and proteins separated by two dimensional electrophoresis 
(2DE). Some of proteins were identified by Mass spectrometry (MS-MALDI method). By using 
bioinformatic analysis illustrate molecular mechanism in this disease. Analysis of gels base on Flicker 
software and Mass Spectrometry led the same result. 61 protein spots detected in both gels that 21 spots 
have down regulated and 12 spots have up regulated in cancerous cell than normal. About 14 spots were 
disappeared in cancer cell while 14 new spots expressed. By using flicker detected 8 Protein that refer 
to TRFE, SZ07, C1 TC, Kininogen, anexin, keratin, fructosebisphosphate aldolase A and heat shock. 
Mass spectrometry (MS-MALDI method) identified anexin, keratin, fructosebisphosphate aldolase A 
and heat shock.  Identified proteins were functionally categorized based on Gene Ontology (GO) 
annotation terms using the DAVID program package. The major molecular functions that annotated 
with PIR include phosphoprotein, disease mutation while annotated by GO include response to organic 
substance, response to wounding  and cellular homeostasis. The cellular component and molecular 
function presenting the greatest enrichment that concluded two clusters that the two most importants are 
cellular homeostasis and extracellular region part. Results reveal that the most of molecular function in 
cancerous tissue maintenance cellular homeostasis, cell regeneration and repair, so tissues undergo 
stress try to survive. It can be also concluded that aldolase A, fructose-bisphosphate, keratin 14,  
formyltetrahydrofolate synthetase and transferrin can be some diagnostic biomarkers and also drug 
targets in esophagus cancer.  
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INTRODUCTION 
     Esophagus cancer is the eighth most common 
cancer worldwide and varies several-hundred-
fold between nations and between geographic 
regions within nations [1]. The incidence is 
particularly high in an area extending from the 
southern border of the Caspian Sea in Iran 
across central Asia to China. Esophagus cancer 
is kind of multifactorial disease that principal 
genetic and epigenetic factors not exactly well 
known so far. Studies indicate that the major 
etiologic risk factors in most developed nations 
are ethanol and cigarette smoking [1, 2]. These 
two factors may convey a significant additive 
effect which is thought to predispose individuals 
to greater risk. For example, alcohol may 
interact with folate, vitamin B12, and methyl 
group metabolism to modulate risk [1, 3]. A 
number of studies suggest an inverse 
relationship between risk of esophageal cancer 
and the consumption of fresh fruits and 
vegetables [1, 4, 5]. The indigenous diet which 
is low in fresh fruits, vegetables, animal 
products, vitamins  and several trace elements 
may be susceptible reason for esophageal cancer 
and parts of Asia where alcohol consumption 
does not the high risk[1,6,7]. In high-risk area 
between Iran and China, micronutrient 
deficiencies coupled with the exposure to 
carcinogenic substances in salt-pickled 
vegetables or moldy foods may be contributing 
factors [1]. Tumor suppressor genes, oncogenes, 
and apoptotic genes are involved in the initiation 
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and development of esophageal cancer, but to 
date no gene directly related to esophageal 
cancer has been identified [2]. Mutations in 
different codons of p53 cause loss of suppressor 
function p53 could be susceptibly various 
esophagus cancers [1, 8].  Over expression of 
p73mRNA was found in 51.8% esophageal 
tumor tissues [9]. The APC is tumor suppressor 
gene like MCC genetic loci occurs in the 
majority of human esophageal cancers and is 
involved in the development and/or progression 
of the disease [10]. P16INK4a and p15INK4b, 
two tumor suppressor genes found to occur less 
frequently in human esophageal cancer in Lixian 
county, China [11]. The oncogenes most 
frequently activated in esophageal cancer are 
cyclin D1, c-erbB1 and 2, FRAT1, c-myc, c-ras, 
Int-2/hst-1, and EGFR [12, 13]. By the way, the 
procedure that is used to analyze changes in 
expression of proteins in a cell is proteomics. In 
proteomic methods by using two dimensional 
electrophoresis and mass spectrometry, gene 
expression can be analyzed. Here the amount of 
expression of proteins in esophageal cancer by 
proteomic techniques were measured and 
compared to the normal. 
 
MATERIALS AND METHODS 
Sampling: 
Normal and cancer esophagus tissues samples 
were taken from patient. Normal tissues sample 
belong to the cancerous patient that give 
cancerous sample. Characteristics of normal and 
cancerous sample were confirm by 
histopathological tests 
Protein Purification: 
Fresh tissue samples of esophagus were snap 
frozen and kept in liquid nitrogen until use. 
Tissue samples were powdered by 
microdismembrator at maximum speed for 60 
seconds under liquid nitrogen conditions. Each 
powdered tissue sample was added to an 
appropriate amount of lysis buffer containing 10 
mM Tris-HCl pH=7.5, 1 mM MgCl2, 1 mM 
EGTA, 0.1 mM Phenylmethylsulfonylfluoride 
(PMSF), 5 mM betamercapto ethanol, 0.5% 
CHAPS and 10% glycerol.25 After 30 minutes 
incubation on ice, the lysate was centrifuged at 
16000g for 30 minutes at 4°C. Protein 
concentration of all samples was estimated using 
a Bradford based microassay [14]. 
Two Dimensional SDS-PAGES:  
The first dimension of 2D electrophoresis was 
performed on the PROTEAN IEF Cell system 
(Bio-Rad). Next, gels were equilibrated for 15 
min in equilibration buffer I (6M urea, 2% SDS, 
0.375 M Tris Hcl pH8.8, 20% glycerol, 130mM 
DTT). A 12% SDS-Polyacrylamide slab gel was 
used for the second dimension gel 
electrophoresis. Equilibrated IPG strips were 
placed on the surface of the second dimension 
gels and then sealed with 0.5% agarose in SDS 
electrophoresis buffer (25mM Tris base, 192mM 
glycine, 0.1%SDS) and were run vertically [15]. 
Coomassie Brilliant Blue Staining:  
After electrophoresis, the gels were stained with 
Coomassie Brilliant Blue staining [16]. 
Mass spectrometry: 
Coomassie Brilliant Blue protein spot containing 
the interested protein was performed to enhance 
peptide adsorption by matrix-assisted laser 
desorption/ionization time-of- flight mass 
spectrometry (MALDI) [17]. The dehydrated gel 
bands were hydrated with 15 μg/L (Promega, 
Madison, WI) of porcine trypsin in 25 mmol/L 
NH4HCO3, pH8.2 on ice for 45 min. Excess 
trypsin was removed; gel bands were covered 
with 25 mmol/L NH4HCO3, pH8.2 and 
incubated at 37℃ overnight. Tryptic peptides 
were extracted from the gel bands with 70% 
acetonitrile and 0.1% trifl uoroacetic acid. 
Sample was desalted with C18 Zip Tips 
(Millipore, Bedford, MA) as per manufacturer's 
protocols. 0.5 μL of sample was co-crystallized 
with 0.5 μL of α-cyano-4-hydroxycinnamic acid 
in 50% acetonitrile, 1% trifluoroacetic acid and 
spotted directly on a stainless steel MALDI 
target plate. Mass spectra were acquired using a 
MALDI-TOF/TOF mass spectrometer (Voyager 
4700, Applied Biosystems, Foster City, CA). 
MALDI-TOF/TOF spectra were internally 
calibrated (< 20 ppm) using trypsin autolysis 
products. Post-acquisition baseline correction 
and smoothing was carried out using software 
provided with the TOF/TOF instrument. Spectra 
were submitted to Mascot 
(http://matrixscience.com) for peptide mass 
fingerprinting. 
Bioinformatic Analysis: 
2DE gels are scanned and gels are analyzed by 
flicker software to compare gels together and 
compare the spots in one statement in gels and 
get the density of same spot in each of gel. Then 
the spots compared to data banks to detection 
the spots in one statement in every experiment 
gel and data bank references gels.. The here 
identified proteins were functionally categorized 
based on Gene Ontology (GO) annotation terms 
using the DAVID program package.  






Figure1: 2DE gel image of a) normal tissue, b) esophagus cancer tissue. The spots correspond to the proteins that 
identified by flicker software 
  




     The separated proteins appear as 
single spots on 2DE gels. The analyzed 
2DE gels of (a) normal and (b) 
cancerous human esophagus tissues are 
represented in figure 1. As it is shown 
in figure 1, 61 spots are labeled in both 
gels that 21 spots have down regulated 
and 12 spots have up regulated in 
cancer tissue than normal tissue. 14 
spots were disappeared in cancer tissue 
while 14 spots newly expressed. The 
next step for analysis the separated 
protein is identification of desired 
spots. There are two ways for protein 
identification based on mass 
spectrometry and using of protein 
databases [17].  As shown in table 1, 
analysis by flicker lead to identification 
of TRFE, SZ07, C1 TC, kininogen, 
annexin, keratin, fructose bisphosphate 
aldolase A and heat shock  (9, 21, 34, 
35, 50, 53, 58 and 61). So Mass 
spectrometry is a potent method for 
protein identification, four desired spots 
corresponded to annexin, keratin, 
fructose bisphosphate aldolase A and 
heat shock, picked and treated for Mass 
spectrometry (MS-MALDI method). 
For confirming flicker findings the two 
methods confirm each other. Table 2 
briefly describes classification of 
detected proteins base on Gene Ontology 
(GO) that categorized according to 
cellular component, molecular function 
and biological process. For functional 
classification of proteins, DAVID 
datasets analysis is done. The results are 
tabulated in table 3 including Functional 
Annotation Clustering and table 4 
Functional Annotation Chart of the 
proteins.  
 
Table 1: The volume of the detected spots in normal and cancer tissues that calculated by flicker software   
 
Mass Spectrometry flicker cancer Normal ID 
 TRFE 60872 118096 9 
 SZ07  22249 21 
 C1 TC 47961 645333 35 
 Kininogen 26980 41367 37 
Anne xin Anne xin 105726 67428 50 
Keratin Keratin 14571  53 
aldolase A aldolase A  9202 58 
Heat s hock Heat s hock 31098 96783 61 
 
DISCUSSION  
    Esophageal cancer is one of the most 
common and highly fatal cancers. To 
identify diagnostic or therapeutic 
biomarkers for this cancer, investigators 
are nowadays performing proteomic 
analyses of cancer tissues and cells and 
revealing a large number of molecules 
which are diagnostic, prognostic and 
informative for carcinogenesis [18]. The 
aim of this study is understanding 
proteomics perspective of esophagus 
cancer in early stages to elucidate their 
tumor biomarkers. Proteomic analysis of 
cancerous and normal esophagus tissues 
as it is displayed in figure 1 depicted 
some alteration in gene expression for 
both tissues. However, some of proteins 
in cancerous tissue are up regulated (12 
spots) the more proteins are down 
regulated (21 spots). The new express 
proteins (14 spots) and disappeared 
proteins (also 14 spots) were detected as 
esophagus cancerous biomarker. It is 
reported in previous study that there are 
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newly expressed protein and disappear protein related to esophagus cancer [19].  
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Previous studies also demonstrated that 
there are several protein biomarkers such 
as annexin and heat shock families related 
to esophagus cancer. These biomarkers 
also are seen in the other gastrointestinal 
cancer and their expressions were altering 
in similar manner [20, 21]. Flicker software 
helps to introduce the proteins by linking to 
the related data banks. Here as shown in 
table 1,  by using Flicker it was detected 
that the 8 spots refer to TRFE, SZ07, C1 
TC, Kininogen, anexin, keratin, 
fructosebisphosphate aldolase A and heat 
shock. Mass spectrometry (MS-MALDI 
method) is a powerful instrument for 
protein identification. The mass results 
confirm that the Flicker finding is real and 
the considered proteins are anexin, keratin, 
fructosebisphosphate aldolase A and heat 
shock. Considering table 2 most of proteins 
are cytoskeleton proteins and also the 
proteins that are presented in stress 
conditions such as diseases and etc. 
Function of some proteins known to 
associate with susceptibility to some cancer 
i.e.  genetic variations in C1TC can 
susceptibility to colorectal cancer [22]. It 
also can increase probability of C1TC to be 
an important key in carcinogenesis of 
esophagus cancer. Reports of proteomic 
analyses of cancerous tissues and 
noncancerous tissues classified the proteins 
into digestive enzymes, growth factors, cell 
adhesion molecules, calcium-binding 
proteins, proteases, protease inhibitors, 
transporter proteins, structural molecules, 
apoptosis inhibitor, molecular chaperone, 
as well as proteins related to cell growth, 
cell differentiation, cell transformation, 
tumor invasion, carcinogen metabolism, 
and others [18].  






Table 3: Functional Annotation Chart by using DAVID software 
 
Category Term Genes % P-Value 
SP_PIR_KEYWORDS duplication  
 
42.9 2.0E-3 








SP_PIR_KEYWORDS blood coagulation  
 
28.6 1.4E-2 
GOTERM_BP_FAT cellular homeostasis  
 
42.9 1.6E-2 
GOTERM_BP_FAT regulation of coagulation  
 
28.6 1.8E-2 








SP_PIR_KEYWORDS plasma  
 
28.6 2.9E-2 
SP_PIR_KEYWORDS phosphoprotein  
 
85.7 3.2E-2 
GOTERM_BP_FAT response to organic substance  
 
42.9 3.7E-2 




Here identified proteins were functionally 
categorized based on Gene Ontology (GO) 
annotation terms using the DAVID program 
package. Amongst other, we found that 8 
proteins were annotated with GO cellular 
component terms. As depicted in table 3, the 
major molecular functions that annotated 
with PIR include phosphoprotein (85.7%), 
disease mutation(57.1%) while annotated by 
GO include response to organic 
substance(50.0%), response to wounding 
(42.9),  purine nucleotide biosynthetic 
process(33.3) and  cellular homeostasis 
(42.9). Disease mutation categorized Protein 
for which at least one variant, responsible for 
a disease, so proteins responsible alteration in 
esophagus cancer may be aldolase A, 
fructose-bisphosphate, keratin 14,  
formyltetrahydrofolate synthetase and 
transferrin . 
 In order to determine whether the cellular 
component and the molecular function 
mentioned above represent functions 
enriched in the esophagus data set relative to 
the “theoretical human proteome”, we used 
DAVID to calculate probable 
overrepresentations of protein classifications 
relative to the annotated human proteome and 
thus excluded common protein functions 
from skewing the functional analysis of the 
esophagus cell sub cellular functions. 
DAVID furthers assigns a statistical 
significance indicator to protein functions 
and classifications. The cellular component 
and molecular function showing the greatest 
enrichment that concluded two clusters in 
table 4.  Cluster1 contains cellular 
homeostasis (1.6E-2) and extracellular region 
part (4.8E-2) that are greatly enriched in our 
dataset.  Furthermore, response to wounding  
and different kind of binding was 
demonstrating the greatest enrichment in 
cluster 2. Results disclose that most of 
molecular function in cancer tissue trying to 
maintenance cellular homeostasis, keeping 
cell regeneration and repair, so tissues 
undergo stress try to survive. It can be also 
concluded that proteins that are detected in 
this study; aldolase A, fructose-bisphosphate, 
keratin 14,  formyltetrahydrofolate synthetase 
and transferrin can be diagnostic or 
therapeutic biomarkers. In order to prove 
these results, it is necessary to have further 
experiments. To be more accurate, it is 
suggested that these biomarkers should be 
analyzed in the mucous secretions and blood.    
 
Table 4: Functional Annotation Clustering by using DAVID software 
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